Enrico Moro Selected Research

5- (3- ethynylphenylamino)pyrimido(4,5- c)quinoline- 8- carboxylic acid

11/2020

"Janus" efficacy of CX-5011: CK2 inhibition and methuosis induction by independent mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enrico Moro Research Topics

Disease

3	Neoplasms (Cancer) 11/2020 - 08/2014
2	Mucopolysaccharidosis II (Hunter Syndrome) 01/2017 - 01/2010
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Gaucher Disease (Gaucher's Disease) 03/2015
1	Fibrosis (Cirrhosis) 12/2014
1	Carcinogenesis 08/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2011
1	Type 2 Diabetes Mellitus (MODY) 01/2010
1	Obesity 01/2010
1	Pituitary Neoplasms (Pituitary Adenoma) 03/2003
1	Male sterility due to Y-chromosome deletions 06/2002
1	Androgen-Insensitivity Syndrome (Testicular Feminization) 01/2002

Drug/Important Bio-Agent (IBA)

4	CateninsIBA 01/2019 - 08/2014
1	Phosphotransferases (Kinase)IBA 11/2020
1	5- (3- ethynylphenylamino)pyrimido(4,5- c)quinoline- 8- carboxylic acidIBA 11/2020
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Glucosylceramidase (Glucocerebrosidase)IBA 03/2015
1	Transcription Factors (Transcription Factor)IBA 12/2014
1	Activins (Activin)IBA 12/2014
1	PyridinesIBA 08/2014
1	PyrimidinesIBA 08/2014
1	LuciferasesIBA 08/2014
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2010
1	Glucagon (Glukagon)FDA Link 01/2010
1	Insulin (Novolin)FDA Link 01/2010
1	GhrelinIBA 01/2010
1	Biological ProductsIBA 01/2010
1	SecurinIBA 03/2003
1	inhibin BIBA 06/2002
1	Androgen Receptors (Androgen Receptor)IBA 01/2002
1	Dihydrotestosterone (Androstanolone)IBA 01/2002

Therapy/Procedure

2	Therapeutics 11/2020 - 01/2011